HIV Treatment and Antiretroviral Therapy
Fundacion Seimc Gesida focuses on clinical research in HIV care, with interest in maintaining virological suppression and evaluating treatment options for adults living with the infection. Its studies examine regimen selection and treatment continuation in people with stable control of HIV.
- Antiretroviral therapy
- Virological suppression
- Treatment switching
The sponsor’s work also includes comparisons of modern integrase inhibitor-based combinations used in long-term management of HIV.
Metabolic Liver Disease in HIV-Infected People
A second area of interest is metabolic liver disease associated with HIV infection, including liver health in individuals receiving ongoing antiretroviral treatment. The research addresses liver fibrosis and non-invasive assessment of hepatic disease burden.
- Liver fibrosis
- Metabolic dysfunction
- Non-invasive liver evaluation
This reflects a clinical focus on liver-related complications that coexist with chronic HIV care.
Regimen Safety and Tolerability
The sponsor is active in studies evaluating the safety and tolerability of switching between established antiretroviral combinations. These trials address treatment suitability in people with good disease control and additional clinical considerations.
- Switching therapy
- Treatment tolerability
- Clinical safety
Particular attention is given to maintaining stable HIV control while assessing regimen compatibility with patient needs.
Neuropsychiatric Vulnerabilities in HIV Care
Another relevant theme is the management of neuropsychiatric vulnerabilities in people living with HIV, especially when considering changes in treatment. The research landscape includes clinical interest in how antiretroviral choices relate to patient well-being beyond viral control.
- Neuropsychiatric symptoms
- Patient vulnerability
- Therapy selection
This area links infectious disease management with attention to mental and neurological health considerations in long-term care.
